 45 PM / Updated 11 minutes ago BRIEF-Baxter Announces U.S. FDA Approval Of Ready-To-Use Bivalirudin Reuters Staff 
Jan 22 (Reuters) - Baxter International Inc: 
* BAXTER ANNOUNCES U.S. FDA APPROVAL OF READY-TO-USE CARDIOVASCULAR MEDICATION BIVALIRUDIN 
* BAXTER INTERNATIONAL SAYS U.S. FDA APPROVED BIVALIRUDIN IN 0.9 PERCENT SODIUM CHLORIDE INJECTION 
* BAXTER INTERNATIONAL INC - BIVALIRUDIN IS EXPECTED TO LAUNCH IN UNITED STATES IN EARLY 2018 Source text for Eikon: Further company coverage: